Radiotherapy For Renal Cell Carcinoma

You might have radiotherapy to help control the symptoms of advanced cancer such as pain or blood in the urine.

Radiotherapy for renal cell carcinoma.

This relieves pressure on nearby organs or nerves that may be causing pain. New advances in rt techniques including stereotactic irradiation have made encouraging contributions in the oncologic scenario opening up new opportunities in rcc management. Study shows the timing of treatments may. Radiotherapy can shrink a larger cancer.

It can also help with bone pain if the cancer has spread to your bones. You can receive the therapy in one to five daily treatments and igrt works well with chemotherapy or between chemotherapy cycles. These techniques provide excellent local control and palliation of metastatic sites of disease with minimal toxicity. Kidney cancer that has spread to the brain.

Radiation is sometimes used to treat kidney cancer if a person is not healthy enough to have surgery or has only one kidney. Radiotherapy is not often used for kidney cancer. Historically renal cell carcinoma has been considered radioresistant. Traditionally renal cell carcinoma rcc has been considered a radioresistant tumor and therefore radiation therapy rt was mainly confined in treatment of metastasis.

However in the past decade evidence has grown that a high dose given in one or a few fractions stereotactic body radiotherapy can overcome resistance. Radiation therapy uses high energy rays or particles to kill cancer cells. Chemotherapy chemo uses anti cancer drugs that are given into a vein iv or taken by mouth as pills. When radiation therapy is used to treat kidney cancer it is usually external beam therapy ebrt which.

Radiation therapy rt has traditionally been disregarded in the primary or adjuvant treatment of renal cell carcinoma rcc but recent advances have necessitated a re examination of the role radiation therapy may be able to play. The radiation dose is precise and very concentrated which is the best way to eliminate kidney cancer cells. Most evidence in favour of stereotactic body radiotherapy for renal cell carcinoma comes from single institution reports. T cells in tumors are expanded in blood shortly after radiation then decrease.

These drugs enter your blood and reach nearly all areas of the body which makes this treatment potentially useful for cancer that has spread metastasized to organs beyond the kidney. Radiation causes key changes to immune cells in kidney cancer tumors. It s a less common treatment since kidney cancer typically resists chemotherapy. Stereotactic radiosurgery and stereotactic body radiation therapy sbrt have led to a resurgence of the use of radiotherapy in the management of advanced renal cell carcinoma rcc.